Identification of Risk Patients in Emergency Medical Services

January 28, 2022 updated by: Marja Mäkinen, Helsinki University Central Hospital
Background: Inadequate nutrition has been associated with growing risk of falling and impaired ability in elderly patients. Falling is a significant threat to the health of the elderly. It is estimated that one third of people over the age of 65 experience at least one falling each year. Over 60% of the falls cause serious injury or disability. Adequate nutrition increases the muscle strength of the elderly. Therefore, determining and managing the nutrition level is important for preventing falling. As far as we know emergency medical services has never before reported being a part of prevention by performing risk identification.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Aim: The purpose of the study is to assess whether it is possible to use a simple screening tool to find out the risk of falling, the nutritional status and the level of cognitive functioning activity when the EMS faces the elderly over the age of 70 years. In addition, the flow of information between primary care and emergency services and nutritionists is examined.

Material and method: Identification of poor nutrition is carried out in the Helsinki University hospital area. All people over the age of 70 requiring ambulance transport will be included in the study for 4 months during 2018. A structured electronic form is used to identify the malnutrition, the level of cognitive functioning activity and the risk of falling. The assessment is performed during the transport. The data is analyzed by the SPSS statistical program both by descriptive and statistical significance by looking at the methods suitable for the data.

Conclusion: The information produced by the research aims to develop (a) Identifying in the ambulance those patients who are at risk; and (b) activating nursing staff and nutritionists and, by means of these measures, increase the number of patients receiving effective nutrition therapy.

Study Type

Observational

Enrollment (Actual)

500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Helsinki Usimaa
      • Helsinki, Helsinki Usimaa, Finland
        • Department of Emergency Medicine and Services, Helsinki University Hospital and Helsinki University, Helsinki, Finland

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

70 years to 104 years (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

All people over the age of 70 requiring ambulance transport will be included in the study for 4 months during 2018 in the Helsinki University hospital area.

Description

Inclusion Criteria:

  • All people over the age of 70 requiring ambulance transport will be included in the study for 4 months during 2018.

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Identifying in the ambulance those patients who are at risk (over 3 points in a single section)
Time Frame: Through study completion an average of 12 months

to use a simple screening tool to find out the risk of falling, the nutritional status and the level of cognitive functioning activity when the EMS faces the elderly over the age of 70 The risk-screening tool is based on valid scales. RISK SCREENING TOOL;

Risk of falling:

Prediction of falls (4 items, 0-3 points) Self-reporting of falls over a 12-month period (3 items, 0-3 points)

Malnutrition Risk:

Home care and meal services (Yes, No) Nutritional status (4 items, 0-3 points) Effect of the diseases on nutrition (4 items, 0-3 points) Age (1 item, 1 point)

Delirium and cognitive functioning:

Alertness / memory / attention deficit / symptoms (4 items, 0-3 points)

Complete when:

> 70 years patient The patient's physical state allows. Mostly completed during transport (no need to add actual time on scene). Possible risk points are reported at donation to the emergency department.

Through study completion an average of 12 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Identifying in the ambulance those patients who are at risk (total scores over sections)
Time Frame: Through study completion an average of 12 months
Subscales are combined to compute a total score, if more than three points in total, the patient is considered to be a risk patient.
Through study completion an average of 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2018

Primary Completion (Actual)

January 28, 2022

Study Completion (Actual)

January 28, 2022

Study Registration Dates

First Submitted

November 15, 2018

First Submitted That Met QC Criteria

November 28, 2018

First Posted (Actual)

November 29, 2018

Study Record Updates

Last Update Posted (Actual)

January 31, 2022

Last Update Submitted That Met QC Criteria

January 28, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • §50, 27.3.2018

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cognitive Impairment

Clinical Trials on Observation

3
Subscribe